Biomarkers in cancer staging, prognosis and treatment selection

被引：1260
作者：
Ludwig, JA
Weinstein, JN [1 ]
机构：
[1] NCI, Genom & Bioinformat Grp, Mol Pharmacol Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA
[2] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
来源：
NATURE REVIEWS CANCER | 2005年 / 5卷 / 11期
关键词：
D O I：
10.1038/nrc1739
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Advances in genomics, proteomics and molecular pathology have generated many candidate biomarkers with potential clinical value. Their use for cancer staging and personalization of therapy at the time of diagnosis could improve patient care. However, translation from bench to bedside outside of the research setting has proved more difficult than might have been expected. Understanding how and when biomarkers can be integrated into clinical care is crucial if we want to translate the promise into reality.
引用
收藏
页码：845 / 856
页数：12
相关论文
共 148 条
[61]   A controlled trial of a human papillomavirus type 16 vaccine [J].
Koutsky, LA ;
Ault, KA ;
Wheeler, CM ;
Brown, DR ;
Barr, E ;
Alvarez, FB ;
Chiacchierini, LM ;
Jansen, KU .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (21) :1645-1651
[62]  
Krohn KA, 2001, Q J NUCL MED, V45, P174
[63]  
Kuge Y, 2004, J NUCL MED, V45, P309
[64]   Genetic polymorphisms of XRCC1 and risk of gastric cancer [J].
Lee, SG ;
Kim, B ;
Choi, JW ;
Kim, C ;
Lee, I ;
Song, K .
CANCER LETTERS, 2002, 187 (1-2) :53-60
[65]   The use and development of germline polymorphisms in clinical oncology [J].
Lenz, HJ .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (13) :2519-2521
[66]  
LEON SA, 1977, CANCER RES, V37, P646
[67]   Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma [J].
Leong, PP ;
Rezai, B ;
Koch, WM ;
Reed, A ;
Eisele, D ;
Lee, DJ ;
Sidransky, D ;
Jen, J ;
Westra, WH .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (13) :972-977
[68]   Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type [J].
Leung, SF ;
Chan, ATC ;
Zee, B ;
Ma, B ;
Chan, LYS ;
Johnson, PJ ;
Lo, YMD .
CANCER, 2003, 98 (02) :288-291
[69]   p53, the cellular gatekeeper for growth and division [J].
Levine, AJ .
CELL, 1997, 88 (03) :323-331
[70]   Transformation of follicular lymphoma to diffuse large-cell lymphoma:: Alternative patterns with increased or decreased expression of c-myc and its regulated genes [J].
Lossos, IS ;
Alizadeh, AA ;
Diehn, M ;
Warnke, R ;
Thorstenson, Y ;
Oefner, PJ ;
Brown, PO ;
Botstein, D ;
Levy, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (13) :8886-8891
234567891011